---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-006090"
form_type: "8-K"
ticker: "TDOC"
cik: "0001477449"
company_name: "Teladoc Health, Inc."
filed_at: "2022-04-27T23:59:59+00:00"
generated_at: "2026-06-26T04:03:37.436261+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Teladoc Q1 net loss $6.67B on $6.6B goodwill impairment; cuts 2022 guidance

## Summary
- Q1 revenue $565.4M (+25% YoY); net loss $6.67B due to $6.6B non-cash goodwill impairment ($41.11/sh).
- Adjusted EBITDA $54.5M (-4% YoY); net loss per share $41.58 vs. $1.31 a year ago.
- FY 2022 guidance revised: revenue $2.4-2.5B, adj. EBITDA $240-265M, net loss per share ($43.50)-($43.00).
- D2C mental health hit by higher ad costs with lower yield; chronic condition sales cycles elongated.
- Primary360 and stepped-care chronic programs launched on multiple new clients in Q1.

## SEC filing metadata
- accession: 0001558370-22-006090
- form_type: 8-K
- ticker: TDOC
- cik: 0001477449
- company_name: Teladoc Health, Inc.
- filed_at: 2022-04-27T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1477449/000155837022006090/0001558370-22-006090-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1477449/000155837022006090/tdoc-20220427x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-006090
- JSON: https://secwatch.observer/filing/0001558370-22-006090.json
- Plain text: https://secwatch.observer/filing/0001558370-22-006090.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.